Increasing Biosimilars Adoption: Providers’ and Patients’ Perspectives
Tuesday, November 9, 2021
1:30 p.m. - 2:30 p.m.
Since the first biosimilar was marketed in 2015, patients and providers have become more familiar and increasingly rely on biosimilars in their course of therapy and medical practice. Iterative efforts to educate patients and providers and facilitate communication about biosimilars have, among other things, led to biosimilars’ use. In this session, speakers will assess biosimilars’ growth, contributing factors, and what steps can be taken to maintain the increased access and savings that biosimilars provide.
Moderator: Melissa Andel, MPP
Principal, CommonHealth Solutions
Vice President, Advocacy & Access, Arthritis Foundation
Kathy Oubre, MS
Co-Chair, Biosimilars Committee, Community Oncology AllianceChief
Operating Officer, Pontchartrain Cancer Center
Eric Tichy, PharmD, MBA
Vice Chair, Pharmacy Supply Solutions, Mayo Clinic